Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficit)

Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning of the period at Sep. 30, 2019	$ 172,612	$ 37,885,151	$ (38,865,060)	$ (807,297)
Balance at the beginning of the period (in shares) at Sep. 30, 2019	172,612,233
Net loss	$ 0	0	(3,296,005)	(3,296,005)
Shares issued for the exercise of warrants	$ 5,182	927,546	0	932,728
Shares issued for the exercise of warrants(in shares)	5,181,819
Issuance of common stock and warrants, net of financing costs	$ 14,286	2,152,876	0	2,167,162
Issuance of common stock and warrants, net of financing costs (in shares)	14,285,714
Stock based compensation expense	$ 0	680,231	0	680,231
Balance at the ending of the period at Jun. 30, 2020	$ 192,080	41,645,804	(42,161,065)	(323,181)
Balance at the ending of the period (in shares) at Jun. 30, 2020	192,079,766
Balance at the beginning of the period at Mar. 31, 2020	$ 186,898	40,534,282	(41,256,698)	(535,518)
Balance at the beginning of the period (in shares) at Mar. 31, 2020	186,897,947
Net loss	$ 0	0	(904,367)	(904,367)
Shares issued for the exercise of warrants	$ 5,182	927,546	0	932,728
Shares issued for the exercise of warrants(in shares)	5,181,819
Stock based compensation expense	$ 0	183,976	0	183,976
Balance at the ending of the period at Jun. 30, 2020	$ 192,080	41,645,804	(42,161,065)	(323,181)
Balance at the ending of the period (in shares) at Jun. 30, 2020	192,079,766
Balance at the beginning of the period at Sep. 30, 2020	$ 193,045	41,862,901	(43,556,437)	$ (1,500,491)
Balance at the beginning of the period (in shares) at Sep. 30, 2020	193,044,766			193,044,766
Net loss	$ 0	0	(4,475,305)	$ (4,475,305)
Issuance of common stock and warrants, net of financing costs	$ 43,125	6,176,108	0	6,219,233
Issuance of common stock and warrants, net of financing costs (in shares)	43,125,004
Issuance of restricted stock	$ 550	(550)	0	0
Issuance of restricted stock (in shares)	550,000
Stock based compensation expense	$ 0	372,196	0	372,196
Balance at the ending of the period at Jun. 30, 2021	$ 236,720	48,410,655	(48,031,742)	$ 615,633
Balance at the ending of the period (in shares) at Jun. 30, 2021	236,719,770			236,719,770
Balance at the beginning of the period at Mar. 31, 2021	$ 236,720	48,316,799	(46,501,837)	$ 2,051,682
Balance at the beginning of the period (in shares) at Mar. 31, 2021	236,719,770
Net loss	$ 0	0	(1,529,905)	(1,529,905)
Stock based compensation expense	0	93,856	0	93,856
Balance at the ending of the period at Jun. 30, 2021	$ 236,720	$ 48,410,655	$ (48,031,742)	$ 615,633
Balance at the ending of the period (in shares) at Jun. 30, 2021	236,719,770			236,719,770